Select a search constraint:
ArrowEVOLUTION™ with Chlorag+ard® technology
The only peripherally inserted central catheter (PICC) that provides broad-spectrum antimicrobial protection1
The application of Chlorag+ard® utilizes a proprietary process whereby chlorhexidine is chemically bonded to the catheter surface, providing a controlled release of the antimicrobial agent. Chlorag+ard® is designed to reduce colonization of pathogens responsible for causing central line–associated bloodstream infections (CLABSIs).
Chlorag+ard® technology complements your facility's efforts toward attaining and sustaining zero CLABSIs by protecting the catheter surfaces where pathogens attach.
Meets the latest stringent regulatory requirements for antimicrobial devices and achieves a 4-log10 reduction, with only 1 in 10,000 surviving organisms.1
|Base-10 logarithmic system||Reduction||Surviving organisms||Examples|
|1-log reduction||90%||1 in 10||NA|
|2-log reduction||99%||1 in 100||NA|
|3-log reduction||99.9%||1 in 1000||ChloraPrep®|
|4-log reduction||99.99%||1 in 10,000||Chlorag+ard® *|
* Chlorag+ard® and ChloraPrep provide effective antimicrobial protection in different environments.
†MRSE = methicillin-resistant Staphylococcus epidermidis; VRE = vancomycin-resistant enterococci; MRSA = methicillin-resistant Staphylococcus aureus; MSSE = methicillin-sensitive Staphylococcus epidermidis; MSSA = methicillin-sensitive Staphylococcus aureus.